Objectives:
- Discus the epidemiology and impact of healthcare-associated (HA) or community-associated (CA) MRSA - Discuss methods to prevent HA- or CA-MRSA Discuss the HA-MRSA prevention/control bundle - Discuss the impact of implementation of the HA-MRSA bundle on HA-MRSA infections in medical or surgical patients
Date
March 11, 2010
Time
1:30-2:30pm Eastern (New York)
Faculty:
Dr. William Jarvis, Jason and Jarvis Associates Teleclass sponsored by Virox Technologies (www.virox.com)
